Helicobacter pylori and extragastric diseases - Other helicobacters

Helicobacter, Supplement

Volumn 10, Issue 1, 2005, Pages 54-65

  Nilsson, Hans Olof ^a   Pietroiusti, Antonio ^b   Gabrielli, Maurizio ^c   Zocco, Maria Assunta ^c   Gasbarrini, Giovanni ^c   Gasbarrini, Antonio ^c  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Animal model; Atherosclerosis; CagA; Enterohepatic; Extragastric disease; Helicobacter

Indexed keywords

ALLERGIC DISEASE; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; GUILLAIN BARRE SYNDROME; HELICOBACTER; HELICOBACTER BILIS; HELICOBACTER BIZZOZERONII; HELICOBACTER FELIS; HELICOBACTER FLEXISPIRA; HELICOBACTER HEILMANNII; HELICOBACTER INFECTION; HELICOBACTER MASTOMYRINUS; HELICOBACTER MURICOLA; HELICOBACTER PYLORI; HELICOBACTER SALOMONIS; HEMATOLOGIC DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPATHOLOGY; MIGRAINE; NONHUMAN; OTITIS MEDIA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TAXONOMY; UPPER RESPIRATORY TRACT INFECTION;

ANIMALIA; FLEXISPIRA; HELICOBACTER; HELICOBACTER HEILMANNII; HELICOBACTER PYLORI; HELICOBACTER SP.; MASTOMYS;

EID: 25844513852     PISSN: 14784041     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2005.00334.x     Document Type: Review

References (125)

1. Preusch MR, Grau AJ, Buggle F, Lichy C, Bartel J, Black C, Rudi J. Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori. Stroke 2004;35:1800-4.
2. Sawayama Y, Ariyama I, Hamada M, Otaguro S, Machi T, Taira Y, Hayashi J. Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT). Atherosclerosis 2005;178:303-9.
3. Diomedi M, Pietroiusti A, Silvestrini M, Rizzato B, Cupini LM, Ferrante F, Magrini A, Bergamaschi A, Galante A, Bernardi G. CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke. Neurology 2004;63:800-4.
4. McDonald SP, Maguire GP, Duarte N, Wang XL, Hoy WE. Carotid intima-media thickness, cardiovascular risk factors and albuminuria in a remote Australian aboriginal community. Atherosclerosis 2004;177:423-31.
5. Shmuely H, Passaro DJ, Vaturi M, Sagie A, Pitlik S, Samra Z, Niv Y, Koren R, Harell D, Yahav J. Association of CagA+ Helicobacter pylori with aortic atheroma. Atherosclerosis 2005;179:127-32.
6. Latsios G, Saetta A, Michalopoulos NV, Agapitos E, Patsouris E. Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by the polymerase chain reaction. Acta Cardiol 2004;59:652-7.
7. Pinar A, Oc M, Akyon Y, Farsak B, Kocyildirim E, Us D, Zorlutuna Y, Tokgozoglu L, Boke E. Investigation of the presence of Chlamydophila pneumoniae, Helicobacter pylori and cytomegalovirus in human atherosclerosis by molecular and serological methods. Mikrobiyol Bul 2004;38:213-22.
8. Skowasch D, Jabs A, Andrie R, Dinkelbach S, Schiele TM, Wernert N, Luderitz B, Bauriedel G. Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis. J Vasc Res 2004;41:525-34.
9. Sulewska A, Modrzejewski W, Kovalchuk O, Kasacka I, Jackowski R, Hirnle T, Musial W, Chyczewski L. Attempts to detect Helicobacter pylori in atherosclerotic plaques. Rocz Akad Med Bialymst 2004;49 (Suppl 1):239-41.
10. Aceti A, Are R, Sabino G, Fenu L, Pasquazzi C, Quaranta G, Zechini B, Terrosu P. Helicobacter pylori active infection in patients with acute coronary heart diseuse. J Infect 2004;49:8-12.
11. Andreica V, Sandica-Andreica B, Draghici A, Chiorean E, Georoceanu A, Rusu M. The prevalence of anti-Helicobacter pylori antibodies in the patients with ischemic heart disease. Rom J Intern Med 2004;42:183-9.
12. Sheehan J, Kearney PM, Sullivan SO, Mongan C, Kelly E, Perry IJ. Acute coronary syndrome and chronic infection in the Cork coronary care case-control study. Heart 2005;91:19-22.
13. Lee SY, Kim DK, Son HJ, Lee JH, Kim YH, Kim JJ, Paik SW, Rhee JC. The impact of Helicobacter pylori infection on coronary heart disease in a Korean population. Korean J Gastroenterol 2004;44:193-8.
14. Lanza GA, Sestito A, Cammarota G, Grillo RL, Vecile E, Cianci R, Speziale D, Dobrina A, Maseri A, Crea F. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol 2004;94:40-4.
15. Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc 2004;96:1470-6.
16. Ongey M, Brenner H, Thefeld W, Rothenbacher D. Helicobacter pylori and hepatitis A virus infections and the cardiovascular risk profile in patients with diabetes mellitus: results of a population-based study. Eur J Cardiovasc Prev Rehabil 2004;11:471-6.
17. Wolf SC, Brehm BR, Mayer O, Jurgens S, Schultze G, Risler T. Infectious risk factors for atherosclerotic vascular disease in hemodialysis patients - Chlamydia pneumoniae but not Helicobacter pylori or cytomegalovirus is associated with increased C-reactive protein. Ren Fail 2004;26:279-87.
18. Assanelli D, Bonanome A, Grassi M, Archetti S, Negrini R, Pezzini A, Curello S, Visioli F. Determinants of early-onset cardiovascular disease: a case-control study of young myocardial infarction patients. Ital Heart J 2004;8:604-11.
19. Limnell V, Pasternack R, Karjalainen J, Virtanen V, Lehtimaki T, Aittoniemi J. Seropositivity for Helicobacter pylori antibodies is associated with lower occurrence of venous bypass graft occlusion. Scand J Infect Dis 2004;36:601-3.
20. Elizalde JI, Perez-Pujol S, Heras M, et al. Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes. Helicobacter 2004;9:681.
21. Davi G, Neri M, Falco A, Festi D, Taraborelli T, Ciabattoni G, Basili S, Cuccurullo F, Patrono C. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. Arterioscler Thromb Vasc Biol 2005;25:246-51.
22. Saribas S, Kocazeybek B, Aslan M, Altun S, Seyhun Y, Oner YA, Memisoglu N. Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections? J Med Microbiol 2004;53:639-44.
23. Consolazio A, Borgia MC, Ferro D, Iacopini F, Paoluzi OA, Crispino P, Nardi F, Rivera M, Paoluzi P. Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic Helicobacter pylori-positive gastritis. Aliment Pharmacol Ther 2004;20:289-94.
24. Kayo S, Ohsawa M, Ehara S, et al. Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction. Am Heart J 2004;148: 818-25.
25. Inaba T, Mizuno M, Take S, et al. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 2005;35:214-9.
26. Ando T, Tsuzuki T, Mizuno T, et al. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter 2004;9:443-52.
27. Fujimura K, Kuwana M, Kurata Y, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 2005;1:162-8.
28. Hashino S, Ota S, Kobayashi S, et al. Current status of treatment for patients with idiopathic thrombocytopenic purpura in the Hokkaido area (evaluation of Helicobacter pylori eradication). Rinsho Ketsueki 2004;45:539-45.
29. Sato K, Nagai T, Muroi K, Komatsu N, Ozawa K. Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: the association between the activity of Helicobacter pylori and platelet recovery. Rinsho Ketsueki 2004;45:1252-4.
30. Kurtoglu E, Kayacetin E, Ugur A. Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura. World J Gastroenterol 2004;10:2113-5.
31. Sato R, Murakami K, Watanabe K, et al. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 2004;164:1904-7.
32. Veneri D, Krampera M, Franchini M. Helicobacter pylori infection and idiopathic thrombocytopenic purpura: description of 21 newly diagnosed cases. Haematologica 2004;89:ECR08.
33. Veneri D, Krampera M, Franchini M. High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study. Platelets 2005;16:117-9.
34. Matsusaki S, Wakita Y, Minamikawa K, Uemura Y, Nakashima K, Yamaguchi T. Platelet recovery of idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori: report of two cases. Nippon Naika Gakkai Zasshi 2004;93: 771-3.
35. Asaumi N, Niiya K, Yoshida C, Shibakura M, Niiya M, Tanimoto M. Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication. Blood Coagul Fibrinolysis 2004;15: 439-40.
36. Kurekci AE, Atay AA, Sarici SU, Ozcan O. Complete platelet recovery after treatment of Helicobacter pylori infection in a child with chronic immune thrombocytopenic purpura: a case report. Pediatr Hematol Oncol 2004;21:593-6.
37. Veneri D, Franchini M. Onset of idiopathic thrombocythemia after Helicobacter pylori eradication. Helicobacter 2005;10:95.
38. Takatsuka H, Wakae T, Toda A, Itoi H, Okada M, Misawa M, Hara H, Kakishita E. Association of Helicobacter pylori with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome after bone marrow transplantation. Clin Transplant 2004;18:547-51.
39. Jackson S, Beck PL, Pineo GF, Poon MC. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol 2005;78:142-50.
40. Ciacci C, Sabbatini F, Cavallaro R, Castiglione F, Di Bella S, Iovino P, Palumbo A, Tortora R, Amoruso D, Mazzacca G. Helicobacter pylori impairs iron absorption in infected individuals. Dig Liver Dis 2004;36:455-60.
41. Keenan JI, Peterson RA, Fraser R, Frampton CM, Walmsley TA, Allardyce RA, Roake JA. The effect of Helicobacter pylori infection and dietary iron deficiency on host iron homeostasis: a study in mice. Helicobacter 2004;9:643-50.
42. Weyermann M, Rothenbacher D, Gayer L, Bode G, Adler G, Grab D, Flock F, Brenner H. Role of Helicobacter pylori infection in iron deficiency during pregnancy. Am J Obstet Gynecol 2005;192:548-53.
43. Roviello F, Fotia G, Marrelli D, De Stefano A, Macchiarelli R, Pinto E. Iron deficiency anemia after subtotal gastrectomy for gastric cancer. Hepatogastroenterology 2004;5:1510-4.
44. Demir H, Saltik IN, Yuce A, Ozen H, Gurakan F, Kocak N. Is there any relation between Helicobacter pylori infection and iron deficiency anemia in children with celiac disease? Helicobacter 2004;9:284.
45. Sarker SA, Davidsson L, Mahmud H, Walczyk T, Hurrell RF, Gyr N, Fuchs GJ. Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi children. Am J Clin Nutr 2004;80:149-53.
46. Diop S, Aouba A, Varet B. Reversal of iron deficiency anaemia after eradication of Helicobacter pylori infection. Presse Med 2004;33:1517-8.
47. Sakabe H, Yagi Y, Kakinoki R, Yoshikawa K, Inoue T, Fujiyama Y. Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori. Rinsho Ketsueki 2004;45:402-4.
48. Jeon BH, Oh YJ, Lee NG, Choe YH. Polymorphism of the Helicobacter pylori feoB gene in Korea: a possible relation with iron-deficiency anemia? Helicobacter 2004;9:330-4.
49. Trimarchi H, Forrester M, Schropp J, Pereyra H, Freixas EA. Low initial vitamin B12 levels in Helicobacter pylori - positive patients on chronic hemodialysis. Nepbron Clin Pract 2004;96:28-32.
50. Van Oijen MG, Laheij RJ, deJong CA, Peters WH, Jansen JB. Vitamin B12 status and its association with Helicobacter pylori infection in alcohol dependent patients. J Nutr Sci Vitaminol 2004;50:305-8.
51. Van Oijen MG, Laheij RJ, Peters WH, Jansen JB, Verheugt FW; BACH study. Association of aspirin use with vitamin B12 deficiency (results of the BACH study). Am J Cardiol 2004;94:975-7.
52. Mete N, Gulbahar O, Aydin A, Sin AZ, Kokuludag A, Sebik F. Low B2 levels in chronic idiopathic urticaria. J Investig Allergol Clin Immunol 2004;14:292-9.
53. Kazimierska E, Podlaska M. Macrocytic megaloblastic anemia in a patient with Helicobacter pylori infection. Pol Merkuriusz Lek 2004;17: 58-9.
54. Jarvis D, Luczynska C, Chinn S, Burney P. The association of hepatitis A and Helicobacter pylori with sensitization to common allergens, asthma and hay fever in a population of young British adults. Allergy 2004;59:1063-7.
55. Kolho KL, Haapaniemi A, Haahtela T, Rautelin H. Helicobacter pylori and specific immunoglobulin E antibodies to food allergens in children. J Pediatr Gastroenterol Nutr 2005;40:180-3.
56. Durazzo M, Rosina F, Premoli A, Morello E, Fagoonee S, Innarella R, Solerio E, Pellicano R, Rizzetto M. Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J Gastroenterol 2004;10:3179-81.
57. Baz K, Cimen MY, Kokturk A, Asian G, Ikizoglu G, Demirseren DD, Kanik A, Atik U. Plasma reactive oxygen species activity and antioxidant potential levels in rosacea patients: correlation with seropositivity to Helicobacter pylori. Int J Dermatol 2004;43:494-7.
58. Aroni K, Tsagroni E, Lazaris AC, Patsouris E, Agapitos E. Rosacea: a clinicopathological approach. Dermatology 2004;209:177-82.
59. Bertalot G, Montresor G, Tampieri M, Spasiano A, Pedroni M, Milanesi B, Favret M, Manca N, Negrini R. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol 2004;61:650-2.
60. Tomasi PA, Dore MP, Fanciulli G, Sanciu F, Realdi G, Delitala G. Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis? Dig Dis Sci 2005;50:385-8.
61. Franceschi F, Satta MA, Mentella MC, et al. Helicobacter pylori infection in patients with Hashimoto's thyroiditis. Helicobacter 2004;9:369.
62. Rybar I, Rovensky J, Masaryk P, Mateicka F, Revayova I. Seroprevalence of Helicobacter pylori in rheumatoid arthritis and its relationship to pharmacotherapy. Vnitr Lek 2004;50:911-6.
63. Di Leo V, D'Inca R, Bettini MB, Podswiadek M, Punzi L, Mastropaolo G, Sturniolo GC. Effect of Helicobacter pylori and eradication therapy on gastrointestinal permeability. Implications for patients with seronegative spondylarthritis. J Rheumatol 2005;32:295-300.
64. El Miedany YM, Baddour M, Ahmed I, Fahmy H. Sjögren's syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine 2005;72:135-41.
65. Vazquez Romero M, Bermejo San Jose F, Boixeda de Miquel D, et al. Chronic urticaria and Helicobacter pylori. Med Clin (Barc) 2004;122: 573-5.
66. Fukuda S, Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004;39:827-30.
67. Buhner S, Reese I, Kuehl F, Lochs H, Zuberbier T. Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability. Allergy 2004;59:1118-23.
68. Mini R, Figura N, D'Ambrosio C, et al. Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics 2005;5:777-87.
69. Koc C, Arikan OK, Atasoy P, Aksoy A. Prevalence of Helicobacter pylori in patients with nasal polyps: a preliminary report. Laryngoscope 2004; 114:1941-4.
70. Malaguarnera M, Bella R, Alagona G, Ferri R, Carnemolla A, Pennisi G. Helicobacter pylori and Alzheimer's disease: a possible link. Eur J Intern Med 2004;15:381-6.
71. Kountouras J, Deretzi G, Zavos C, Karatzoglou P, Touloumis L, Nicolaides T, Chatzopoulos D, Venizelos I. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2005;12:139-43.
72. Tunca A, Turkay C, Tekin O, Kargili A, Erbayrak M. Is Helicobacter pylori infection a risk factor for migraine? A case-control study. Acta Neurol Belg 2004;104:161-4.
73. Budzynski J, Klopocka M, Bujak R, Swiatkowski M, Pulkowski G, Sinkiewicz W. Autonomic nervous function in Helicobacter pylori-infected patients with atypical chest pain studied by analysis of heart rate variability. Eur J Gastroenterol Hepatol 2004;16:451-7.
74. Ioannou GN, Weiss NS, Kearney DJ. Is Helicobacter pylori seropositivity related to body mass index in the United States? Aliment Pharmacol Ther 2005;21:765-72.
75. Nishi Y, Isomoto H, Uotani S, Wen CY, Shikuwa S, Ohnita K, Mizuta Y, Kawaguchi A, Inoue K, Kohno S. Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol 2005;11:695-9.
76. Tatsuguchi A, Miyake K, Gudis K, Futagami S, Tsukui T, Wada K, Kishida T, Fukuda Y, Sugisaki Y, Sakamoto C. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am J Gastroenterol 2004;99:2121-7.
77. Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y, Sugano K. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005;90:10-6.
78. Kamada T, Hata J, Kusunoki H, Ito M, Tanaka S, Kawamura Y, Chayama K, Haruma K. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis 2005;37:39-43.
79. Masaoka T, Suzuki H, Imaeda H, Hosoda H, Ohara T, Morishita T, Ishii H, Kangawa K, Hibi T. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication. Hepatogastroenterology 2005;52:1-4.
80. Pitkaranta A, Kolho KL, Rautelin H. Helicobacter pylori in children who are prone to upper respiratory tract infections. Arch Otolaryngol Head Neck Surg 2005;131:256-8.
81. Roussos A, Philippou N, Krietsepi V, Anastasakou E, Alepopoulou D, Koursarakos P, Iliopoulos I, Gourgoulianis K. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease. Respir Med 2005;99:279-84.
82. Pronai L, Schandl L, Orosz Z, Magyar P, Tulassay Z. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Helicobacter 2004;9:278-83.
83. Candelli M, Rigante D, Marietti G, et al. Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. J Pediatr Gastroenterol Nutr 2004;38:422-5.
84. Lo MK, Lee KF, Chan NN, et al. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy. Diabetes Obes Metab 2004;6:223-30.
85. Baricevic I, Nedic O, Nikolic JA, Bojic B, Jojic N. Circulating insulin-like growth factors in patients infected with Helicobacter pylori. Clin Biochem 2004;37:997-1001.
86. Pearce MS, Steele JG, Campbell DI, Thomas JE. Tooth loss and Helicobacter pylori seropositivity: the Newcastle Thousand Families Cohort Study at age 49-51 years. Helicobacter 2005;10:90-4.
87. Albanidou-Farmaki E, Giannoulis L, Markopoulos A, Fotiades S, Aggouridaki X, Farmakis K, Papanayotou P. Outcome following treatment for Helicobacter pylori in patients with recurrent aphthous stomatitis. Oral Dis 2005;11:22-6.
88. Ahnoux-Zabsonre A, Quaranta M, Mauget-Faysse M. of Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy: a complementary study. J Fr Ophtalmol 2004;27:1129-33.
89. Miller DM, Espinosa-Heidmann DG, Legra J, Dubovy SR, Suner IJ, Sedmak DD, Dix RD, Cousins SW. The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol 2004;138:323-8.
90. Nurgalieva ZZ, Graham DY, Dahlstrom KR, Wei Q, Sturgis EM. A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. Head Neck 2005;27:22-7.
91. Akbayir N, Basak T, Seven H, Sungun A, Erdem L. Investigation of Helicobacter pylori colonization in laryngeal neoplasia. Eur Arch Otorhinolaryngol 2005;262:170-2.
92. Philippou N, Koursarakos P, Anastasakou E, Krietsepi V, Mavrea S, Roussos A, Alepopoulou D, Iliopoulos I. Helicobacter pylori seroprevalence in patients with lung cancer. World J Gastroenterol 2004;10:3342-4.
93. Rossi G, Romagnoli S, Lauretti L, Pancotto L, Taccini E, Rappuoli R, Del Giudice G, Ruggiero P. Helicobacter pylori infection negatively influences pregnancy outcome in a mouse model. Helicobacter 2004;9:152-7.
94. Abayli B, Colakoglu S, Serin M, Erdogan S, Isiksal YF, Tuncer I, Koksal F, Demiryurek H. Helicobacter pylori in the etiology of cholesterol gallstones. Clin Gastroenterol 2005;39:134-7.
95. Rocha M, Avenaud P, Menard A, Le Bail B, Balabaud C, Bioulac-Sage P, de Magalhaes Queiroz DM, Megraud F. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005;54:396-401.
96. Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF, Li N. Identification of Helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 2004;57:1273-7.
97. Sethar GH, Ahmed R, Zuberi BF, Afsar S. Frequency of Helicobacter pylori antibodies in porto-systemic encephalopathy. J Coll Physicians Surg Pak 2004;14:530-3.
98. O'Rourke JL, Solnick JV, Neilan BA, Seidel K, Hayter R, Hansen LM, Lee A. Description of 'Candidatus Helicobacter heilmannii' based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol 2004;54:2203-11.
99. Shen Z, Xu S, Dewhirst FE, Paster BJ, Pena JA, Modlin IM, Kidd M, Fox JG. A novel enterohepatic Helicobacter species 'Helicobacter mastomyrinus' isolated from the liver and intestine of rodents. Helicobacter 2005;10:59-70.
100. Mikkonen TP, Kärenlampi RI, Hänninen ML. Phylogenetic analysis of gastric and enterohepatic Helicobacter species based on partial HSP60 gene sequences. Int J Syst Evol Microbiol 2004;54: 753-8.
101. Hänninen ML, Kärenlampi RI, Koort JM, Mikkonen T, Björkroth KJ. Extension of the species Helicobacter bilis to include the reference strains of Helicobacter sp. flexispira taxa 2, 3 and 8 and Finnish canine and feline flexispira strains. Int J Syst Evol Microbiol 2005;55:891-8.
102. Bourgade F, Montagutelli X, Bigbee C, Weiss A, Rigottier-Gois L, Conti CJ, Benavides F. Simple duplex fecal PCR assay that allows identification of false-negative results in Helicobacter sp.-infected mice. Comp Med 2004;54:528-32.
103. Feng S, Ku K, Hodzic E, Lorenzana E, Freet K, Barthold SW. Differential detection of five mouse-infecting Helicobacter species by multiplex PCR. Clin Diagn Lab Immunol 2005;12:531-6.
104. Feng S, Kendall LV, Hodzic E, Wong S, Lorenzana E, Freet K, Ku KS, Luciw PA, Barthold SW, Khan IH. Recombinant Helicobacter bilis protein P167 for mouse serodiagnosis in a multiplex microbead assay. Clin Diagn Lab Immunol 2004;11:1094-9.
105. Chan V, Crocetti G, Grehan M, Zhang L, Danon S, Lee A, Mitchell H. Visualization of Helicobacter species within the murine cecal mucosa using specific fluorescence in situ hybridization. Helicobacter 2005;10:114-24.
106. Young VB, Knox KA, Pratt JS, Cortez JS, Mansfield LS, Rogers AB, Fox JG, Schauer DB. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun 2004;72:2521-7.
107. Hynes SO, Ferris JA, Szponar B, et al. Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enteric helicobacters. Helicobacter 2004;9:313-23.
108. Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG, Wang TC, Kurt-Jones EA. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not Toll-like receptor 4. Infect Immun 2004;72:6446-54.
109. Cui G, Koh TJ, Chen D, Zhao CM, Takaishi S, Dockray GJ, Varro A, Rogers AB, Fox JG, Wang TC. Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach. Cancer Res 2004;64:8160-6.
110. Nomura S, Baxter T, Yamaguchi H, Leys C, Vartapetian AB, Fox JG, Lee JR, Wang TC, Goldenring JR. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. Gastroenterol 2004;127:582-94.
111. Stoicov C, Whary M, Rogers AB, et al. Co-infection modulates inflammatory responses and clinical outcome of Helicobacter felis and Toxoplasma gondii infections. J Immunol 2004;173:3329-36.
112. O'Rourke JL, Dixon MF, Jack A, Enno A, Lee A. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of "Helicobacter heilmannii" infection. J Pathol 2004;203:896-903.
113. Rogers AB, Boutin SR, Whary MT, Sundina N, Ge Z, Cormier K, Fox JG. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 2004;32:668-77.
114. Boutin SR, Rogers AB, Shen Z, Fry RC, Love JA, Nambiar PR, Suerbaum S, Fox JG. Hepatic temporal gene expression profiling in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 2004;32:678-93.
115. Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, Carey MC, Fox JG. Identification of cholelithogenic enterohepatic Helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 2005;128:1023-33.
116. Myles MH, Livingston RS, Franklin CL. Pathogenicity of Helicobacter rodentium in A/JCr and SCID mice. Comp Med 2004;54:549-57.
117. Livingston RS, Myles MH, Livingston BA, Criley JM, Franklin CL. Sex influence on chronic intestinal inflammation in Helicobacter hepaticus-infected A/JCr mice. Comp Med 2004;54:301-8.
118. Pena JA, Rogers AB, Ge Z, Ng V, Li SY, Fox JG, Versalovic J. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun 2005;73:912-20.
119. Fox JG, Rogers AB, Whary MT, Taylor NS, Xu S, Feng Y, Keys S. Helicobacter bilis-associated hepatitis in outbred mice. Comp Med 2004;54:571-7.
120. Nilsson HO, Ouis IS, Stenram U, Ljungh A, Moran AP, Wadstrom T, Al-Soud WA. High prevalence of Helicobacter species detected in laboratory mouse strains by multiplex PCR-denaturing gradient gel electrophoresis and pyrosequencing. J Clin Microbiol 2004;42: 3781-8.
121. Goto K, Jiang W, Zheng Q, Oku Y, Kamiya H, Itoh T, Ito M. Epidemiology of Helicobacter infection in wild rodents in the Xinjiang-Uygur autonomous region of China. Curr Microbiol 2004;49:221-3.
122. Van den Bulck K, Baele M, Hermans K, Ducatelle R, Haesebrouck F, Decostere A. First report on the occurrence of 'Helicobacter heilmannii' in the stomach of rabbits. Vet Res Commun 2005;29:271-9.
123. Park JH, Seok SH, Cho SA, Baek MW, Lee HY, Kim DJ, Park JH. The high prevalence of Helicobacter sp. in porcine pyloric mucosa and its histopathological and molecular characteristics. Vet Microbiol 2004;104:219-25.
124. Terio KA, Munson L, Marker L, Aldridge BM, Solnick JV. Comparison of Helicobacter spp. in cheetahs (Acinonyx jubatus) with and without gastritis. J Clin Microbiol 2005;41:229-34.
125. Oxley AP, Powell M, McKay DB. Species of the family Helicobacteraceae detected in an Australian sea lion (Neophoca cinerea) with chronic gastritis. J Clin Microbiol 2004;42:3505-12.